| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1833 |
| Trial ID | NCT03373071 |
| Disease | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL |
| Year | 2017 |
| Country | Italy |
| Company sponsor | Bambino Gesù Hospital and Research Institute |
| Other ID(s) | CD19-CAR01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||